Global Leukapheresis Products Market

Leukapheresis Products Comprehensive Study by Type (Leukapheresis Devices, Apheresis Devices, Leukapheresis Columns & Cell Separators, Leukoreduction Filters, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End User (Blood Component Providers and Blood Centers, Hospitals and Transfusion Centers, Others) Players and Region - Global Market Outlook to 2030

Leukapheresis Products Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 8.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Leukapheresis Products
The method of removing irregular white blood cells (WBCs) from the blood is known as leukapheresis. Leukaemia can be treated with leukapheresis, or it can be used as the first step of CAR T-cell therapy. An increase in the number of blood donors and the incidence of leukaemia are some factors that are anticipated to propel the growth of the market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR8.3%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Leukapheresis Products market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Haemonetics Corporation (United States), Terumo BC, Inc (United States), Asahi Kasei Medical Co. Ltd. (Japan), Guangzhou Daji Medical Science and Technology Co. Ltd. (China), Macopharma SA (France), Caltag Medsystem Limited (United Kingdom), ZenBio (United States), Fresenius SE & Co. KGaA (Germany) and Lonza Group AG (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are HemaCare Corporation (United States) and ALLCells, LLC (United States).

Segmentation Overview
AMA Research has segmented the market of Global Leukapheresis Products market by Type (Leukapheresis Devices, Apheresis Devices, Leukapheresis Columns & Cell Separators, Leukoreduction Filters and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications) and Region.



On the basis of geography, the market of Leukapheresis Products has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Blood Component Providers and Blood Centers will boost the Leukapheresis Products market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers:
Rising Prevalence of Leukemia and Increasing Number of Blood Donations

Challenges:
Dearth of Skilled Professionals and Stringent Donor Recruitment Criteria

Restraints:
High Cost of Products

Opportunities:
Growing Demand for Leukopaks in Clinical Research and Demand from Emerging Economies and Increasing Investments from Leading Players

Market Leaders and their expansionary development strategies
In January 2023, Sanguine Biosciences ("Sanguine"), a leader in connecting patients with biopharmaceutical companies to accelerate precision medicine R&D and Cell & Gene Therapy, announced today a new investment from BroadOak Capital Partners, LLC ("BroadOak"), a leading direct investment and advisory firm focused on life science research tools, pharmaceutical services and diagnostics. The partnership with BroadOak enables Sanguine to expand its laboratory operations, leukapheresis offerings, and patient donor network.
In May 2023, Akadeum Life Sciences, a global leader in buoyancy-based cell separation and activation technology, is announcing the launch of a new series of products for cell therapy research and development—enabling direct leukopak human immune cell isolation and T-cell activation/expansion kits at the American Society of Gene + Cell Therapy’s


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Leukapheresis Products Manufacturer, Raw Material Suppliers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Leukapheresis Devices
  • Apheresis Devices
  • Leukapheresis Columns & Cell Separators
  • Leukoreduction Filters
  • Leukapheresis Disposables
By Application
  • Research Applications
  • Therapeutic Applications
By End User
  • Blood Component Providers and Blood Centers
  • Hospitals and Transfusion Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Leukemia
      • 3.2.2. Increasing Number of Blood Donations
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Professionals
      • 3.3.2. Stringent Donor Recruitment Criteria
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Leukapheresis Products, by Type, Application, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Leukapheresis Products (Value)
      • 5.2.1. Global Leukapheresis Products by: Type (Value)
        • 5.2.1.1. Leukapheresis Devices
        • 5.2.1.2. Apheresis Devices
        • 5.2.1.3. Leukapheresis Columns & Cell Separators
        • 5.2.1.4. Leukoreduction Filters
        • 5.2.1.5. Leukapheresis Disposables
      • 5.2.2. Global Leukapheresis Products by: Application (Value)
        • 5.2.2.1. Research Applications
        • 5.2.2.2. Therapeutic Applications
      • 5.2.3. Global Leukapheresis Products by: End User (Value)
        • 5.2.3.1. Blood Component Providers and Blood Centers
        • 5.2.3.2. Hospitals and Transfusion Centers
        • 5.2.3.3. Others
      • 5.2.4. Global Leukapheresis Products Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Leukapheresis Products (Price)
      • 5.3.1. Global Leukapheresis Products by: Type (Price)
  • 6. Leukapheresis Products: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Haemonetics Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Terumo BC, Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Asahi Kasei Medical Co. Ltd. (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Guangzhou Daji Medical Science and Technology Co. Ltd. (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Macopharma SA (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Caltag Medsystem Limited (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ZenBio (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fresenius SE & Co. KGaA (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lonza Group AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Leukapheresis Products Sale, by Type, Application, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Leukapheresis Products (Value)
      • 7.2.1. Global Leukapheresis Products by: Type (Value)
        • 7.2.1.1. Leukapheresis Devices
        • 7.2.1.2. Apheresis Devices
        • 7.2.1.3. Leukapheresis Columns & Cell Separators
        • 7.2.1.4. Leukoreduction Filters
        • 7.2.1.5. Leukapheresis Disposables
      • 7.2.2. Global Leukapheresis Products by: Application (Value)
        • 7.2.2.1. Research Applications
        • 7.2.2.2. Therapeutic Applications
      • 7.2.3. Global Leukapheresis Products by: End User (Value)
        • 7.2.3.1. Blood Component Providers and Blood Centers
        • 7.2.3.2. Hospitals and Transfusion Centers
        • 7.2.3.3. Others
      • 7.2.4. Global Leukapheresis Products Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Leukapheresis Products (Price)
      • 7.3.1. Global Leukapheresis Products by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Leukapheresis Products: by Type(USD Million)
  • Table 2. Leukapheresis Products Leukapheresis Devices , by Region USD Million (2018-2023)
  • Table 3. Leukapheresis Products Apheresis Devices , by Region USD Million (2018-2023)
  • Table 4. Leukapheresis Products Leukapheresis Columns & Cell Separators , by Region USD Million (2018-2023)
  • Table 5. Leukapheresis Products Leukoreduction Filters , by Region USD Million (2018-2023)
  • Table 6. Leukapheresis Products Leukapheresis Disposables , by Region USD Million (2018-2023)
  • Table 7. Leukapheresis Products: by Application(USD Million)
  • Table 8. Leukapheresis Products Research Applications , by Region USD Million (2018-2023)
  • Table 9. Leukapheresis Products Therapeutic Applications , by Region USD Million (2018-2023)
  • Table 10. Leukapheresis Products: by End User(USD Million)
  • Table 11. Leukapheresis Products Blood Component Providers and Blood Centers , by Region USD Million (2018-2023)
  • Table 12. Leukapheresis Products Hospitals and Transfusion Centers , by Region USD Million (2018-2023)
  • Table 13. Leukapheresis Products Others , by Region USD Million (2018-2023)
  • Table 14. South America Leukapheresis Products, by Country USD Million (2018-2023)
  • Table 15. South America Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 16. South America Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 17. South America Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 18. Brazil Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 19. Brazil Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 20. Brazil Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 21. Argentina Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 22. Argentina Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 23. Argentina Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 24. Rest of South America Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 25. Rest of South America Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 26. Rest of South America Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 27. Asia Pacific Leukapheresis Products, by Country USD Million (2018-2023)
  • Table 28. Asia Pacific Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 29. Asia Pacific Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 31. China Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 32. China Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 33. China Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 34. Japan Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 35. Japan Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 36. Japan Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 37. India Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 38. India Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 39. India Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 40. South Korea Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 41. South Korea Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 42. South Korea Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 43. Taiwan Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 44. Taiwan Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 45. Taiwan Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 46. Australia Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 47. Australia Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 48. Australia Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 52. Europe Leukapheresis Products, by Country USD Million (2018-2023)
  • Table 53. Europe Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 54. Europe Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 55. Europe Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 56. Germany Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 57. Germany Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 58. Germany Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 59. France Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 60. France Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 61. France Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 62. Italy Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 63. Italy Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 64. Italy Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 65. United Kingdom Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 66. United Kingdom Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 67. United Kingdom Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 68. Netherlands Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 69. Netherlands Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 70. Netherlands Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 71. Rest of Europe Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 72. Rest of Europe Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 73. Rest of Europe Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 74. MEA Leukapheresis Products, by Country USD Million (2018-2023)
  • Table 75. MEA Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 76. MEA Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 77. MEA Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 78. Middle East Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 79. Middle East Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 80. Middle East Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 81. Africa Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 82. Africa Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 83. Africa Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 84. North America Leukapheresis Products, by Country USD Million (2018-2023)
  • Table 85. North America Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 86. North America Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 87. North America Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 88. United States Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 89. United States Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 90. United States Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 91. Canada Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 92. Canada Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 93. Canada Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 94. Mexico Leukapheresis Products, by Type USD Million (2018-2023)
  • Table 95. Mexico Leukapheresis Products, by Application USD Million (2018-2023)
  • Table 96. Mexico Leukapheresis Products, by End User USD Million (2018-2023)
  • Table 97. Leukapheresis Products: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Leukapheresis Products: by Type(USD Million)
  • Table 108. Leukapheresis Products Leukapheresis Devices , by Region USD Million (2025-2030)
  • Table 109. Leukapheresis Products Apheresis Devices , by Region USD Million (2025-2030)
  • Table 110. Leukapheresis Products Leukapheresis Columns & Cell Separators , by Region USD Million (2025-2030)
  • Table 111. Leukapheresis Products Leukoreduction Filters , by Region USD Million (2025-2030)
  • Table 112. Leukapheresis Products Leukapheresis Disposables , by Region USD Million (2025-2030)
  • Table 113. Leukapheresis Products: by Application(USD Million)
  • Table 114. Leukapheresis Products Research Applications , by Region USD Million (2025-2030)
  • Table 115. Leukapheresis Products Therapeutic Applications , by Region USD Million (2025-2030)
  • Table 116. Leukapheresis Products: by End User(USD Million)
  • Table 117. Leukapheresis Products Blood Component Providers and Blood Centers , by Region USD Million (2025-2030)
  • Table 118. Leukapheresis Products Hospitals and Transfusion Centers , by Region USD Million (2025-2030)
  • Table 119. Leukapheresis Products Others , by Region USD Million (2025-2030)
  • Table 120. South America Leukapheresis Products, by Country USD Million (2025-2030)
  • Table 121. South America Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 122. South America Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 123. South America Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 124. Brazil Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 125. Brazil Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 126. Brazil Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 127. Argentina Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 128. Argentina Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 129. Argentina Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 130. Rest of South America Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 131. Rest of South America Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 132. Rest of South America Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 133. Asia Pacific Leukapheresis Products, by Country USD Million (2025-2030)
  • Table 134. Asia Pacific Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 135. Asia Pacific Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 136. Asia Pacific Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 137. China Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 138. China Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 139. China Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 140. Japan Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 141. Japan Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 142. Japan Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 143. India Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 144. India Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 145. India Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 146. South Korea Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 147. South Korea Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 148. South Korea Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 149. Taiwan Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 150. Taiwan Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 151. Taiwan Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 152. Australia Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 153. Australia Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 154. Australia Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 155. Rest of Asia-Pacific Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 156. Rest of Asia-Pacific Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 158. Europe Leukapheresis Products, by Country USD Million (2025-2030)
  • Table 159. Europe Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 160. Europe Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 161. Europe Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 162. Germany Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 163. Germany Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 164. Germany Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 165. France Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 166. France Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 167. France Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 168. Italy Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 169. Italy Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 170. Italy Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 171. United Kingdom Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 172. United Kingdom Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 173. United Kingdom Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 174. Netherlands Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 175. Netherlands Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 176. Netherlands Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 177. Rest of Europe Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 178. Rest of Europe Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 179. Rest of Europe Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 180. MEA Leukapheresis Products, by Country USD Million (2025-2030)
  • Table 181. MEA Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 182. MEA Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 183. MEA Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 184. Middle East Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 185. Middle East Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 186. Middle East Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 187. Africa Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 188. Africa Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 189. Africa Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 190. North America Leukapheresis Products, by Country USD Million (2025-2030)
  • Table 191. North America Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 192. North America Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 193. North America Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 194. United States Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 195. United States Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 196. United States Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 197. Canada Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 198. Canada Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 199. Canada Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 200. Mexico Leukapheresis Products, by Type USD Million (2025-2030)
  • Table 201. Mexico Leukapheresis Products, by Application USD Million (2025-2030)
  • Table 202. Mexico Leukapheresis Products, by End User USD Million (2025-2030)
  • Table 203. Leukapheresis Products: by Type(USD/Units)
  • Table 204. Research Programs/Design for This Report
  • Table 205. Key Data Information from Secondary Sources
  • Table 206. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Leukapheresis Products: by Type USD Million (2018-2023)
  • Figure 5. Global Leukapheresis Products: by Application USD Million (2018-2023)
  • Figure 6. Global Leukapheresis Products: by End User USD Million (2018-2023)
  • Figure 7. South America Leukapheresis Products Share (%), by Country
  • Figure 8. Asia Pacific Leukapheresis Products Share (%), by Country
  • Figure 9. Europe Leukapheresis Products Share (%), by Country
  • Figure 10. MEA Leukapheresis Products Share (%), by Country
  • Figure 11. North America Leukapheresis Products Share (%), by Country
  • Figure 12. Global Leukapheresis Products: by Type USD/Units (2018-2023)
  • Figure 13. Global Leukapheresis Products share by Players 2023 (%)
  • Figure 14. Global Leukapheresis Products share by Players (Top 3) 2023(%)
  • Figure 15. Global Leukapheresis Products share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Haemonetics Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Haemonetics Corporation (United States) Revenue: by Geography 2023
  • Figure 19. Terumo BC, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 20. Terumo BC, Inc (United States) Revenue: by Geography 2023
  • Figure 21. Asahi Kasei Medical Co. Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 22. Asahi Kasei Medical Co. Ltd. (Japan) Revenue: by Geography 2023
  • Figure 23. Guangzhou Daji Medical Science and Technology Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 24. Guangzhou Daji Medical Science and Technology Co. Ltd. (China) Revenue: by Geography 2023
  • Figure 25. Macopharma SA (France) Revenue, Net Income and Gross profit
  • Figure 26. Macopharma SA (France) Revenue: by Geography 2023
  • Figure 27. Caltag Medsystem Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Caltag Medsystem Limited (United Kingdom) Revenue: by Geography 2023
  • Figure 29. ZenBio (United States) Revenue, Net Income and Gross profit
  • Figure 30. ZenBio (United States) Revenue: by Geography 2023
  • Figure 31. Fresenius SE & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Fresenius SE & Co. KGaA (Germany) Revenue: by Geography 2023
  • Figure 33. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Lonza Group AG (Switzerland) Revenue: by Geography 2023
  • Figure 35. Global Leukapheresis Products: by Type USD Million (2025-2030)
  • Figure 36. Global Leukapheresis Products: by Application USD Million (2025-2030)
  • Figure 37. Global Leukapheresis Products: by End User USD Million (2025-2030)
  • Figure 38. South America Leukapheresis Products Share (%), by Country
  • Figure 39. Asia Pacific Leukapheresis Products Share (%), by Country
  • Figure 40. Europe Leukapheresis Products Share (%), by Country
  • Figure 41. MEA Leukapheresis Products Share (%), by Country
  • Figure 42. North America Leukapheresis Products Share (%), by Country
  • Figure 43. Global Leukapheresis Products: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Haemonetics Corporation (United States)
  • Terumo BC, Inc (United States)
  • Asahi Kasei Medical Co. Ltd. (Japan)
  • Guangzhou Daji Medical Science and Technology Co. Ltd. (China)
  • Macopharma SA (France)
  • Caltag Medsystem Limited (United Kingdom)
  • ZenBio (United States)
  • Fresenius SE & Co. KGaA (Germany)
  • Lonza Group AG (Switzerland)
Additional players considered in the study are as follows:
HemaCare Corporation (United States) , ALLCells, LLC (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 224 Pages 68 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Leukapheresis Products Market Quantitative research analysis
Global Leukapheresis Products Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Haemonetics Corporation (United States), Terumo BC, Inc (United States), Asahi Kasei Medical Co. Ltd. (Japan), Guangzhou Daji Medical Science and Technology Co. Ltd. (China), Macopharma SA (France), Caltag Medsystem Limited (United Kingdom), ZenBio (United States), Fresenius SE & Co. KGaA (Germany) and Lonza Group AG (Switzerland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"" is seen as one of major influencing trends for Leukapheresis Products Market during projected period 2023-2030.
The Leukapheresis Products market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Leukapheresis Products Market Report?

Have a Query? Click Here

Other Related Reports

Medical Devices Vigilance Comprehensive Study by Application (Diagnostic Application, Therapeutic Application, Surgical Application, Research Application, Other), Deployment Mode (On-premise Delivery...
$ 3750
Remote Dispensing System Comprehensive Study by Application (Hospitals, Long-term care facilities, Retail pharmacies, Others), Patient Type (In-patient, Outpatients), Deployment Type (On-Premise, Clo...
$ 3500
Laparoscopic Clip Appliers Comprehensive Study by Type (Reusable Clip Appliers, Disposable Clip Appliers), Application (Hospitals, Clinics, Ambulatory Surgical Centers, Others) Players and Region - G...
$ 3500
Rapid test devices Comprehensive Study by Application (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Drugs-of-Abuse Testing, Fertility, Pregnancy Testing, Others), Technolo...
$ 3650
Medical Imaging Lens Comprehensive Study by Type (Imaging Systems, Optical Imaging Systems, Spectral Imaging Systems, Cameras, Illumination systems, Other), Application (Pathological Imaging, Intra-o...
$ 3750
Lung Biopsy Device Comprehensive Study by Type (Needle-based Biopsy Instruments (Core Biopsy Devices, Aspiration Biopsy Needles, Vacuum-assisted Biopsy Devices), Localization Wires, Procedure Trays, ...
$ 3750